Novel KRAS Inhibitors for Treating Non-small Cell Lung Cancer.
Rachel MataPublished in: ACS medicinal chemistry letters (2024)
Provided herein are novel KRAS inhibitors, pharmaceutical compositions, use of such compounds in treating non-small cell lung cancer, and processes for preparing such compounds.
Keyphrases